Overview

The Feasibility of Florbetapir Quantitation in Europe

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether the addition of quantitation as an adjunct to visual interpretations significantly improves the accuracy of Amyvid scan interpretation.
Phase:
Phase 4
Details
Lead Sponsor:
Avid Radiopharmaceuticals